1. Home
  2. LIQT vs TRIB Comparison

LIQT vs TRIB Comparison

Compare LIQT & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiqTech International Inc.

LIQT

LiqTech International Inc.

N/A

Current Price

$2.10

Market Cap

13.7M

Sector

Technology

ML Signal

N/A

TRIB

Trinity Biotech plc

HOLD

Current Price

$0.62

Market Cap

14.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIQT
TRIB
Founded
2004
1992
Country
Denmark
Ireland
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
14.0M
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
LIQT
TRIB
Price
$2.10
$0.62
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.30
N/A
AVG Volume (30 Days)
19.4K
89.7K
Earning Date
05-13-2026
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$42.12
$13.51
Revenue Next Year
$63.48
$13.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.22
$0.50
52 Week High
$3.35
$3.44

Technical Indicators

Market Signals
Indicator
LIQT
TRIB
Relative Strength Index (RSI) 61.96 41.42
Support Level $2.19 $0.50
Resistance Level $2.56 $0.76
Average True Range (ATR) 0.23 0.04
MACD 0.01 -0.01
Stochastic Oscillator 75.44 6.93

Price Performance

Historical Comparison
LIQT
TRIB

About LIQT LiqTech International Inc.

LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in businesses that are liquid filtration market and the silicon carbide ceramic membrane & diesel particulate filter (DPF) market. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and others. Its operating segment includes Water, Ceramics, and Plastics.

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

Share on Social Networks: